PYC Therapeutics moves into final stage of child blindness study
PYC Therapeutics (ASX:PYC) has been approved to escalate doses of its drug…
Pyc Therapeutics Limited (ASX:PYC)
About Pyc Therapeutics Limited
Key Information
PYC In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 09.25am 05/11/2024 | Price Sensitive PS RP11 SRC Approves Dose Escalation to Final Patient Cohort | 259.08KB | 1.0K |
| 01/11/2024 | Price Sensitive PS First ADOA Patient Dosed in Clinical Trial | 279.88KB | 2.9K |
| 31/10/2024 | Presentation of RP11 Single Dose Data at RANZCO | 228.31KB | 528 |
| 25/10/2024 | Price Sensitive PS Quarterly Activities/Appendix 4C Cash Flow Report | 580.87KB | 6.6K |
| 22/10/2024 | Price Sensitive PS Interim Update on Progress in RP11 Repeat Dose Trials | 272.88KB | 14K |
| 21/10/2024 | Price Sensitive PS Trading Halt | 561.45KB | 16K |
| 21/10/2024 | Price Sensitive PS US FDA Grants Orphan Drug Designation to PYC Drug Candidate | 232.46KB | 1.5K |
| 14/10/2024 | Price Sensitive PS Notice of Annual General Meeting/Proxy Form | 677.61KB | 6.3K |